Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07369739 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Golidocitinib Combined With Selinexor for CAEBVD

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is a multicenter, prospective, single-arm clinical investigation, with patients with CAEBVD as the main research subjects, to evaluate the effectiveness of the combined treatment regimen of golidocitinib and selinexor.
Trial Details
NCT Number NCT07369739
Lead Sponsor Beijing Friendship Hospital
Conditions
(from sponsor)		 Lymphohistiocytosis, EBV, CAEBV
Enrollment 28 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov